Pharmacists in Nappanee, IN Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Crystal Stickel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 242 N Oakland Ave, Nappanee, IN 46550 Phone: 574-773-7873 Fax: 574-773-3673 |
Dr. Kwanta Nathalang Wu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1654 E Market St # 06467, Nappanee, IN 46550 Phone: 574-773-4311 |
Linda Jean Letherman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 242 N Oakland Ave, Nappanee, IN 46550 Phone: 574-773-7873 Fax: 574-773-3673 |
 Larry Alan Fredericks Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 242 N Oakland Ave, Nappanee, IN 46550 Phone: 574-773-7873 Fax: 574-773-3673 |
News Archive
NextGen clients secure $2 million in reimbursements from PQRI program
Clients of NextGen Healthcare Information Systems, Inc. have secured nearly $2 million in reimbursements from the Physician Quality Reporting Initiative program by leveraging NextGen Ambulatory EHR and the NextGen Health Quality Measures Reporting Module, a proprietary, clinical data repository designed for automated registry reporting of clinical outcomes and quality measure data for pay-for-performance programs.
Study offers clues to potential treatments for preserving, restoring insulin-producing cells
In type 1 diabetes, the body relentlessly attacks and destroys its own insulin-producing pancreatic beta cells. But a study by Joslin Diabetes Center scientists now has firmly established that some of these cells endure for many decades in a small group of people with the disease—offering clues to potential treatments for preserving and even restoring the crucial cell population.
Study on kidneys may help to treat high blood pressure
A study of the body system that deals with Americans' love affair with salt may yield more insight into why so many end up hypertensive and how to better treat them.
FDA panel schedules review for U-Systems' somo•v ABUS system
U-Systems, the leader in automated breast ultrasound, today announced the somo•v Automated Breast Ultrasound (ABUS) system has been scheduled for review by the Radiological Devices Panel of the U.S. Food & Drug Administration (FDA) on April 11, 2012.
› Verified 9 days ago